The ASC inflammasome adapter controls the extent of peripheral protein aggregate deposition in inflammation-associated amyloidosis
暂无分享,去创建一个
S. Hornemann | A. Aguzzi | P. Picotti | K. Nilsson | P. Schwarz | N. Rupp | M. Polymenidou | G. Westermark | M. Nuvolone | K. Frontzek | M. Emmenegger | M. Losa | R. Reimann | N. Pengo | T. Serdiuk | Itzel Condado Morales | A. Lakkaraju | P. de Rossi | A. Theocharides | V. Lysenko | P. Schürch | Danaëlle Capron | M. Carta | Mirzet Delic | A. Theocharides | Dimitri Bieli
[1] K. Tracey,et al. Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis , 2020, Science Translational Medicine.
[2] J. Lukens,et al. AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment , 2020, Nature.
[3] Ishan Agrawal,et al. Comprehensive review of ASC structure and function in immune homeostasis and disease , 2020, Molecular Biology Reports.
[4] Julia C. Engelmann,et al. High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination , 2019, Molecular oncology.
[5] B. Hazenberg,et al. Causes of AA amyloidosis: a systematic review , 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[6] L. Buée,et al. NLRP3 inflammasome activation drives tau pathology , 2019, Nature.
[7] E. Latz,et al. Platelets Fuel the Inflammasome Activation of Innate Immune Cells , 2019, bioRxiv.
[8] R. Demirci,et al. Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart – Review Study , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[9] I. Roterman,et al. Amyloids, Congo red and the apple-green effect. , 2019, Acta biochimica Polonica.
[10] N. Grigorieff,et al. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids , 2019, Nature Communications.
[11] K. Öllinger,et al. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis , 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[12] R. Papa,et al. Secondary, AA, Amyloidosis. , 2018, Rheumatic diseases clinics of North America.
[13] George H Sack,et al. Serum amyloid A – a review , 2018, Molecular Medicine.
[14] S. Saito,et al. CD11c+ M1-like macrophages (MΦs) but not CD206+ M2-like MΦ are involved in folliculogenesis in mice ovary , 2018, Scientific Reports.
[15] M. Heneka,et al. Neuroinflammatory responses in Alzheimer’s disease , 2018, Journal of Neural Transmission.
[16] D. Brough,et al. Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responses , 2018, Scientific Reports.
[17] J. Moon,et al. Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis , 2018, Science Translational Medicine.
[18] M. Heneka,et al. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease , 2017, Nature.
[19] K. Tsuneyama,et al. CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors , 2017, Nature Communications.
[20] P. Walther,et al. Cellular mechanism of fibril formation from serum amyloid A1 protein , 2017, EMBO reports.
[21] G. Merlini,et al. Systemic amyloidosis: novel therapies and role of biomarkers. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] R. Ye,et al. Serum amyloid A1: Structure, function and gene polymorphism. , 2016, Gene.
[23] K. Nilsson,et al. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[24] I. Dewachter,et al. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease , 2016, Journal of Neuroinflammation.
[25] Michele Vendruscolo,et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models , 2016, Nature Protocols.
[26] R. Ye,et al. Emerging functions of serum amyloid A in inflammation , 2015, Journal of leukocyte biology.
[27] P. Pelegrín,et al. Isolation of Particles of Recombinant ASC and NLRP3. , 2015, Bio-protocol.
[28] Hao Wu,et al. The hierarchical structural architecture of inflammasomes, supramolecular inflammatory machines. , 2015, Current opinion in structural biology.
[29] M. Heneka,et al. Innate immunity in Alzheimer's disease , 2015, Nature Immunology.
[30] M. Fändrich,et al. AA amyloidosis: pathogenesis and targeted therapy. , 2015, Annual review of pathology.
[31] Michael T. Heneka,et al. Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.
[32] S. Hornemann,et al. ASC has extracellular and prionoid activities that propagate inflammation , 2014, Nature Immunology.
[33] Vishva M. Dixit,et al. Mechanisms and Functions of Inflammasomes , 2014, Cell.
[34] E. Erdem,et al. Red Cell Distribution Width and Mean Platelet Volume in Amyloidosis , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[35] Katherine A. Fitzgerald,et al. Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes , 2014, Cell.
[36] S. Kennel,et al. Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[37] G. Westermark,et al. Depletion of Spleen Macrophages Delays AA Amyloid Development: A Study Performed in the Rapid Mouse Model of AA Amyloidosis , 2013, PloS one.
[38] P. Disterer,et al. Pathogenetic mechanisms of amyloid A amyloidosis , 2013, Proceedings of the National Academy of Sciences.
[39] A. Aguzzi,et al. Efficient amyloid A clearance in the absence of immunoglobulins and complement factors. , 2013, The American journal of pathology.
[40] G. Westermark,et al. AA-Amyloid is cleared by endogenous immunological mechanisms , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[41] H. Anders,et al. The inflammasomes in kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.
[42] M. Baumann,et al. Serum Amyloid A Activates the NLRP3 Inflammasome via P2X7 Receptor and a Cathepsin B-Sensitive Pathway , 2011, The Journal of Immunology.
[43] A. Aguzzi,et al. Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. , 2010, The American journal of pathology.
[44] P. Westermark,et al. Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis , 2009, FEBS letters.
[45] S. Ozen,et al. Expression of ASC in Renal Tissues of Familial Mediterranean Fever Patients with Amyloidosis: Postulating a Role for ASC in AA Type Amyloid Deposition , 2008, Experimental biology and medicine.
[46] J. Šponarová,et al. AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes , 2008, PloS one.
[47] M. Goldman. Faculty Opinions recommendation of Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. , 2008 .
[48] Richard A. Flavell,et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.
[49] E. Alnemri,et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation , 2007, Cell Death and Differentiation.
[50] J. Liepnieks,et al. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[51] R. Ménard,et al. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation , 2005, Annals of the rheumatic diseases.
[52] Christian Leisner,et al. Raft lipids as common components of human extracellular amyloid fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] V. Dixit,et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf , 2004, Nature.
[54] J. Liepnieks,et al. Amyloid-enhancing factor mediates amyloid formation on fibroblasts via a nidus/template mechanism. , 2003, Arthritis and rheumatism.
[55] J. Liepnieks,et al. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. , 2002, Arthritis and rheumatism.
[56] P. Westermark,et al. Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[57] C. Röcken,et al. Pathology, diagnosis and pathogenesis of AA amyloidosis , 2002, Virchows Archiv.
[58] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[59] J. Liepnieks,et al. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. , 1995, Biochimica et biophysica acta.
[60] R. Kisilevsky,et al. Direct Evidence for Circulating apoSAA as the Precursor of Tissue AA Amyloid Deposits , 1988, Scandinavian journal of immunology.
[61] M. Pras,et al. Degradation and deposition of amyloid AA fibrils are tissue specific. , 1987, Biochemistry.
[62] E. Alnemri,et al. Assembly, purification, and assay of the activity of the ASC pyroptosome. , 2008, Methods in enzymology.
[63] A. Komatsuda,et al. [Secondary (AA) amyloidosis]. , 1998, Ryoikibetsu shokogun shirizu.
[64] R. Kisilevsky,et al. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy. , 1983, Laboratory investigation; a journal of technical methods and pathology.